Myxoma tumour cells, including ETCs and MTCs, expressed a relatively high level of genes encoding most immune checkpoint ligands, such as galectin‐3, PD‐L1, VSIG‐3, CD155, CD112 and CEACAM1. This evidence concerns the gene NECTIN2 and myxoma.